EDGAR Filing Documents for 0001193125-11-037943

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-11-037943

Filing Date

2011-02-16

Accepted

2011-02-16 17:00:06

Documents

Period of Report

2010-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	2424466
2	FORM OF AMENDMENT TO AMENDMENT TO EQUITY/LONG-TERM INCENTIVE AWARD AGREEMENT	dex1024.htm	EX-10.24	5136
3	STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES	dex121.htm	EX-12.1	6226
4	SUBSIDIARIES OF THE REGISTRANT	dex211.htm	EX-21.1	1039
5	CONSENT OF STONEFIELD JOSEPHSON, INC.	dex231.htm	EX-23.1	1864
6	CONSENT OF MARCUM LLP	dex232.htm	EX-23.2	1982
7	CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302	dex311.htm	EX-31.1	7207
8	CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302	dex312.htm	EX-31.2	7836
9	CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER	dex32.htm	EX-32	7117
10	GRAPHIC	g138566g53l26.jpg	GRAPHIC	64242
	Complete submission text file	0001193125-11-037943.txt		2552950

Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119

Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100

CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)